Get started
Author

Alex De Caluwé

Observed names: A De Caluwe, A De Caluwé, A. De Caluwe, A. De Caluwé, A. de Caluwé, Alex De Caluwe, Alex de Caluwe, Alex de Caluwé, Caluwe, Alex De, Caluwé, Alex De, De Caluwe, Alex, De Caluwé, Alex
ORCID: 0000-0001-5989-7017
Observed ORCID: 0000-0001-5989-7017
OpenAlex ID: A5065137747
Immunotherapy in breast cancer: an overview of current strategies and perspectives
2023 · Véronique Debien, Alex De Caluwé, et al. · npj Breast Cancer · 368
PDF
EGFR mutation status on brain metastases from non-small cell lung cancer
2016 · Fred Hsu, Alex De Caluwe, et al. · Lung Cancer · 129
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges
2023 · Xiaoxiao Wang, Laetitia Collet, et al. · Journal of Clinical Medicine · 64
PDF
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
2019 · Sandra Tuyaerts, An M. T. Van Nuffel, et al. · BMC Cancer · 62
PDF
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
2022 · Emiel A. De Jaeghere, Sandra Tuyaerts, et al. · Cancer Immunology Immunotherapy · 50
PDF
Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study
2017 · Fred Hsu, Alan Nichol, et al. · Acta Oncologica · 41
PDF
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial
2021 · Alex De Caluwé, Laurence Buisseret, et al. · BMC Cancer · 36
PDF
Patterns of Spread and Prognostic Implications of Lung Cancer Metastasis in an Era of Driver Mutations
2017 · Fred Hsu, A. De Caluwe, et al. · Current Oncology · 36
PDF
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
2023 · David Pasquier, Luc Bidaut, et al. · The Lancet Oncology · 34
PDF
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial
2023 · Alex De Caluwe, Emanuela Romano, et al. · Journal for ImmunoTherapy of Cancer · 28
Radiation therapy for young women with early breast cancer: Current state of the art
2019 · Icro Meattini, Matteo Lambertini, et al. · Critical Reviews in Oncology/Hematology · 25
PDF
Split-VMAT technique to control the deep inspiration breath hold time for breast cancer radiotherapy
2021 · Sara Poeta, Younes Jourani, et al. · Radiation Oncology · 16
PDF
Automated segmentation in planning-CT for breast cancer radiotherapy: A review of recent advances
2024 · Zineb Smine, Sara Poeta, et al. · Radiotherapy and Oncology · 15
LBA10 Primary endpoint results of the Neo-CheckRay phase II trial evaluating stereotactic body radiation therapy (SBRT) +/- durvalumab (durva) +/- oleclumab (ole) combined with neo-adjuvant chemotherapy (NACT) for early-stage, high risk ER+/HER2- breast cancer (BC)
2024 · A. De Caluwe, I. Desmoulins, et al. · Annals of Oncology · 14
PDF
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
2022 · Elisa Agostinetto, Flavia Jacobs, et al. · Cancers · 13
PDF
Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry
2022 · Catherine Philippson, Samuel Larsen, et al. · Breast Cancer Research · 12
PDF
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
2024 · Emiel A. De Jaeghere, Hannelore Hamerlinck, et al. · Gynecologic Oncology · 10
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers
2023 · Melanie Machiels, Redouane Oulkadi, et al. · The Breast · 9
PDF
Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis
2026 · Luca Arecco, Pedro M. Cacilhas, et al. · The Breast · 8
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial
2025 · A De Caluwé, S. Bellal, et al. · Radiotherapy and Oncology · 8
PDF
Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
2023 · Sofian Benkhaled, Kadiatou Diakité, et al. · Radiation Oncology · 8
PDF
Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT
2022 · Sofian Benkhaled, Carolina Gomes da Silveira Cauduro, et al. · Frontiers in Oncology · 8
PDF
ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives – Endorsed by ASTRO
2025 · Alice Zamagni, Angel Montero Luis, et al. · Radiotherapy and Oncology · 7
PDF
Unlocking the therapeutic potential of immuno-radiotherapy: insights from preclinical and clinical research
2026 · M. M. Cogels, A. de Caluwé, et al. · OncoImmunology · 6
PDF
Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT
2021 · Imane Ahrouch, Dirk Van Gestel, et al. · Radiotherapy and Oncology · 6
Works count: 77
Citation count: 1,048
H-index: 14
I10-index: 17
Year
Topic
Type